A detailed history of Guardcap Asset Management LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Guardcap Asset Management LTD holds 20,854 shares of NVO stock, worth $2.98 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
20,854
Previous 35,797 41.74%
Holding current value
$2.98 Million
Previous $3.7 Million 27.71%
% of portfolio
0.03%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $1.53 Million - $2.03 Million
-14,943 Reduced 41.74%
20,854 $2.68 Million
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $28,879 - $34,693
-329 Reduced 0.91%
35,797 $3.7 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.41 Million - $3.09 Million
15,496 Added 75.11%
36,126 $3.29 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $1.15 Million - $1.28 Million
-7,393 Reduced 26.38%
20,630 $3.34 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $91,579 - $110,124
-692 Reduced 2.41%
28,023 $4.46 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $292,164 - $385,555
-2,849 Reduced 9.03%
28,715 $3.89 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $67,931 - $80,150
-658 Reduced 2.04%
31,564 $3.52 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $60,328 - $72,925
-648 Reduced 1.97%
32,222 $3.58 Million
Q4 2021

Feb 10, 2022

SELL
$95.88 - $117.08 $110,070 - $134,407
-1,148 Reduced 3.37%
32,870 $3.68 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $484,992 - $612,531
5,745 Added 20.32%
34,018 $3.27 Million
Q2 2021

Aug 17, 2021

SELL
$67.66 - $84.76 $97,565 - $122,223
-1,442 Reduced 4.85%
28,273 $2.37 Million
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $117,086 - $132,381
-1,746 Reduced 5.55%
29,715 $2 Million
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $63,762 - $73,652
-998 Reduced 3.07%
31,461 $2.2 Million
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $94,324 - $103,995
1,481 Added 4.78%
32,459 $2.25 Million
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $190,723 - $221,348
3,258 Added 11.75%
30,978 $2.03 Million
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $61,973 - $81,169
-1,253 Reduced 4.32%
27,720 $1.67 Million
Q4 2019

Feb 13, 2020

SELL
$49.86 - $58.26 $51,256 - $59,891
-1,028 Reduced 3.43%
28,973 $1.68 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $85,191 - $95,746
1,792 Added 6.35%
30,001 $1.55 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $3,041 - $3,410
-65 Reduced 0.23%
28,209 $1.44 Million
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $188,731 - $214,256
-4,071 Reduced 12.59%
28,274 $1.48 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $923,060 - $1.05 Million
22,221 Added 219.49%
32,345 $1.49 Million
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $473,398 - $518,753
10,124 New
10,124 $477,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Guardcap Asset Management LTD Portfolio

Follow Guardcap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardcap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Guardcap Asset Management LTD with notifications on news.